Medical College Physicians Announces New CEO, John R. Schreiber, MD, MPH
From 2014-2016, Dr. Schreiber served as president of Baystate Medical Practices in Springfield, Mass.
Milwaukee, Jan. 31, 2017 – Medical College Physicians (MCP), the Medical College of Wisconsin’s (MCW) adult patient care practice, announces the appointment of John R. Schreiber, MD, MPH, as Chief Executive Officer of MCP and Senior Associate Dean for Clinical Affairs – Adult Practice, effective April 20, 2017.
MCP represents more than 1,200 physicians and providers in approximately 38 specialties who practice at five health systems, 10 hospitals and 38 clinics throughout Wisconsin. MCP comprises two-thirds of the clinical faculty at MCW.
From 2014-2016, Dr. Schreiber served as president of Baystate Medical Practices in Springfield, Mass. and chief physician executive at Baystate Health. He also served as regional executive dean at University of Massachusetts-Baystate and professor of Pediatrics at the University of Massachusetts Medical School.
Dr. Schreiber graduated from Haverford College in Haverford, Pa. in 1976 and received his MD degree from Tulane University School of Medicine in New Orleans in 1980. He also received a Master of Public Health degree from Tulane University School of Public Health and Tropical Medicine in 1979. From 1980-1982, Dr. Schreiber completed an internship and residency in Pediatrics at Children’s Hospital (Boston, Mass). He served a clinical fellowship in Infectious Diseases at Children’s Hospital from 1982-1983, and a research fellowship in Infectious Diseases at Harvard Medical School and Children’s Hospital from 1983-1985.
From 1985-1986, Dr. Schreiber was an Instructor in Pediatrics at Harvard Medical School. He served as Assistant Professor of Pediatrics at Albany Medical College from 1986-1988 in New York. In 1988, Dr. Schreiber joined Case Western Reserve University School of Medicine in Cleveland, where he served in the following capacities: assistant professor of Pediatrics (1988-1993); associate professor of Pediatrics (1993-2000); associate professor of Pathology (1998-2000); professor of Pediatrics and Pathology (2000-2004). From 2004-2007, Dr. Schreiber was adjunct professor of Microbiology and Ruben-Bentson Endowed Chair, professor and head of the Department of Pediatrics at the University of Minnesota Medical School in Minneapolis. He served as David and Leona Karp Professor and Chair, Department of Pediatrics, Tufts University School of Medicine in Boston from 2007-2014; professor, Tufts University Clinical and Translational Science Institute from 2009-2014; and professor in the Program of Immunology of the Sackler School of Graduate Biomedical Sciences at Tufts University from 2011-2014.
Dr. Schreiber served with the United States Air Force (USAF) in a number of capacities, including active duty in Operation Desert Storm; Major, Captain and Lt. Colonel in the USAF Medical Corps (Reserve), and Flight Surgeon, 757 Tactical Airlift Squadron. He received an Honorable Discharge from the USAF Reserve in 2005.
Dr. Schreiber’s laboratory at Case Western Reserve University School of Medicine focused on host defense against encapsulated bacteria and the role of IgG subclass on anti-capsular antibody function, and yielded several patents. He also was a course instructor for Mechanisms of Infection and the Immunology of Infectious Diseases. At the University of Minnesota, his lab expanded its focus to include the role of TACI in the production of anti-polysaccharide antibodies and antigen processing of glycoconjugate vaccines.
Dr. Schreiber has served on numerous committees for the Pediatric Infectious Diseases Society, the Infectious Disease Society of America, the American Association of Immunologists, the Advocacy Committee for the Society for Pediatric Research and the Federation of American Societies for Experimental Biology Board of Directors. Dr. Schreiber also has served on NIH study sections and VA Merit Review Boards and has participated in Food and Drug Administration site visits. Honored for his achievements in the field of advocacy for medical research, Dr. Schreiber was the recipient of the 2012 Distinguished Service Award from the American Association of Immunologists.
Dr. Schreiber has participated in more than 100 invited lectures, workshops and presentations, both nationally and internationally. His bibliography includes more than 135 articles, book chapters and abstracts.
Dr. Schreiber will be relocating from western Massachusetts with his wife, Rebecca Cronin Schreiber. They have two adult sons who live in Washington, DC and West Virginia.
About the Medical College of Wisconsin
The Medical College of Wisconsin is the state’s only private medical school and health sciences graduate school. Founded in 1893, it is dedicated to leadership and excellence in education, patient care, research and community engagement. More than 1,200 students are enrolled in MCW’s medical school and graduate school programs in Milwaukee, 56 medical students enrolled at MCW-Green Bay, and 26 students matriculated to MCW-Central Wisconsin in 2016. MCW’s School of Pharmacy will open in 2017 or 2018 with an initial class size of 60 students. A major national research center, MCW is the largest research institution in the Milwaukee metro area and second largest in Wisconsin. In FY 2014-15, faculty received approximately $158 million in external support for research, teaching, training and related purposes, of which approximately $139 million is for research. This total includes highly competitive research and training awards from the National Institutes of Health (NIH). Annually, MCW faculty direct or collaborate on more than 3,200 research studies, including clinical trials. Additionally, more than 1,500 physicians provide care in virtually every specialty of medicine for more than 525,000 patients annually.
Mentioned in This Press Release
Recent Press Releases by Medical College of Wisconsin
Inducted as Chair of the Council of Deans of the American Association of Medical Colleges
MCW ranked at 471.
Late-life major depression is a growing public health issue already affecting more than 5 million individuals in the US.